Allogene Therapeutics, Inc. (ALLO) vs Bright Minds Biosciences Inc. (DRUG)
A side-by-side comparison of Allogene Therapeutics, Inc. and Bright Minds Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLO
Allogene Therapeutics, Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
DRUG
Bright Minds Biosciences Inc.
$48.25HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — ALLO vs DRUG
growth of $100 · dividends reinvested · last 6yALLO -95.9% (-41.4%/yr)DRUG +84.4% (+10.7%/yr)DRUG compounded faster over this window
Log scale — wide-divergence pair
ALLO DRUG
ALLO vs DRUG: by the numbers
- •ALLO is the larger company ($508M vs $472M market cap).
- •Both run net losses; DRUG's is the smaller (0.00% vs -3566.68% net margin).
Metrics side by side
Valuation
| Metric | ALLO | DRUG |
|---|---|---|
| P/S ratio | 109.52 | N/A |
| P/B ratio | 1.17 | 2.18 |
Profitability
| Metric | ALLO | DRUG |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -3566.68% | 0.00% |
| ROE | -37.94% | -8.21% |
| ROIC | -34.79% | -13.15% |
Growth (annualized)
| Metric | ALLO | DRUG |
|---|---|---|
| Revenue CAGR (5Y) | -34.47% | N/A |
| Total return CAGR (5Y) | -42.72% | 6.76% |
Frequently asked
- How have ALLO and DRUG total returns compared?
- Over the past 5 years, ALLO delivered -42.72% and DRUG delivered 6.76% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.